Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Tango Therapeutics, Inc. - Common Stock (NQ:TNGX)

22.61 +0.29 (+1.32%)

Streaming Delayed Price Updated: 11:06 AM EDT, Sep 3, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	229,182
Open	22.50
Bid (Size)	22.60 (100)
Ask (Size)	22.63 (100)
Prev. Close	22.32
Today's Range	22.13 - 22.71
52wk Range	6.250 - 34.39
Shares Outstanding	88,406,523
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Tango Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference

September 01, 2026

From Tango Therapeutics, Inc.

Via GlobeNewswire

Tango Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights

August 11, 2026

From Tango Therapeutics, Inc.

Via GlobeNewswire

Performance

YTD	+153.2%	+153.2%
1 Month	-16.9%	-16.9%
3 Month	+5.3%	+5.3%
6 Month	+83.1%	+83.1%
1 Year	+239.6%	+239.6%

More News

Tango Therapeutics Announces Executive Chair Transition

August 06, 2026

From Tango Therapeutics, Inc.

Via GlobeNewswire

Tango Therapeutics Appoints Robert Azelby to Board of Directors

June 22, 2026

From Tango Therapeutics, Inc.

Via GlobeNewswire

Tango Therapeutics Announces Pricing of $600 Million Upsized Public Offering

June 09, 2026

From Tango Therapeutics, Inc.

Via GlobeNewswire

Tango Therapeutics Announces Proposed $500 Million Public Offering

June 08, 2026

From Tango Therapeutics, Inc.

Via GlobeNewswire

These stocks are moving in today's session ↗

June 08, 2026

Via Chartmill

Top stock movements in today's session. ↗

June 08, 2026

Via Chartmill

These stocks are gapping in today's session ↗

June 08, 2026

Via Chartmill

Monday's pre-market session: top gainers and losers ↗

June 08, 2026

Via Chartmill

Tango Therapeutics Announces Combination of Vopimetostat and Daraxonrasib Demonstrated 92% Objective Response Rate in Pancreatic Cancer

June 08, 2026

From Tango Therapeutics, Inc.

Via GlobeNewswire

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 05, 2026

From Tango Therapeutics, Inc.

Via GlobeNewswire

Tango Therapeutics Stock Is Up 840%, and This Fund Just Disclosed Buying $164 Million More ↗

May 29, 2026

Via The Motley Fool

Acuta Capital Sells 56% of Ocular Therapeutix Shares in Q1 ↗

May 26, 2026

Via The Motley Fool

Boxer Capital’s $18 Million Corvus Pharma Bet Signals Confidence in This Biotech’s Next Phase ↗

May 17, 2026

Via The Motley Fool

Why One Healthcare Fund Increased Its Kodiak Sciences Stake Amid an Eye-Popping Rally ↗

May 17, 2026

Via The Motley Fool

Vir Biotechnology Stock Has Doubled This Past Year. One Fund Just Bought 1.2 Million Shares ↗

May 17, 2026

Via The Motley Fool

Acuta Capital Bet on Erasca (ERAS) and Targeted Cancer Treatments With a 354,575 Share Buy ↗

May 16, 2026

Via The Motley Fool

Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights

May 13, 2026

From Tango Therapeutics, Inc.

Via GlobeNewswire

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 04, 2026

From Tango Therapeutics Sub, Inc

Via GlobeNewswire

Tango Therapeutics Announces Leadership Appointments to Accelerate Late-Stage Development of Vopimetostat

April 15, 2026

From Tango Therapeutics Sub, Inc

Via GlobeNewswire

Tango Therapeutics President Sells 27,000 Shares for $572,000 as Share Price Skyrockets ↗

April 08, 2026

Via The Motley Fool

Tango Therapeutics Insider Sells $304,000 in Stock Amid a 36% Single-Day Surge ↗

March 30, 2026

Via The Motley Fool

Is Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet. ↗

March 19, 2026

Via The Motley Fool

Nextech Trims Kymera at a Recent High — think Foolishly before acting. ↗

March 19, 2026

Via The Motley Fool

Frequently Asked Questions

Is Tango Therapeutics, Inc. - Common Stock publicly traded?

Yes, Tango Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Tango Therapeutics, Inc. - Common Stock trade on?

Tango Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Tango Therapeutics, Inc. - Common Stock?

The ticker symbol for Tango Therapeutics, Inc. - Common Stock is TNGX on the Nasdaq Stock Market

What is the current price of Tango Therapeutics, Inc. - Common Stock?

The current price of Tango Therapeutics, Inc. - Common Stock is 22.61

When was Tango Therapeutics, Inc. - Common Stock last traded?

The last trade of Tango Therapeutics, Inc. - Common Stock was at 09/03/26 11:06 AM ET

What is the market capitalization of Tango Therapeutics, Inc. - Common Stock?

The market capitalization of Tango Therapeutics, Inc. - Common Stock is 2.00B

How many shares of Tango Therapeutics, Inc. - Common Stock are outstanding?

Tango Therapeutics, Inc. - Common Stock has 2B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.